April-June operating profit up 40.6% YoY, raised full-year ordinary profit forecast.
ผลกระทบต่อหุ้น 7
Reported 8.8% rise in Q1 operating profit and announced share buyback.
Q1 operating profit up 17.4% YoY, share buyback and shareholder benefits well received.
Cuorips received approval for insurance reimbursement price of its iPS cell-derived cardiomyocyte sheet.
Keyence reported Q1 operating profit up 44.7% YoY, beating consensus by ~30 billion yen.
Developed microwave technology usable in open spaces and filed patent application.
Q1 operating profit surged 66.9% YoY, beating market expectations by ~12 billion yen.